Share Name Share Symbol Market Type Share ISIN Share Description
Fevertree Drinks LSE:FEVR London Ordinary Share GB00BRJ9BJ26 ORD 0.25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -65.00p -4.34% 1,434.00p 1,427.00p 1,430.00p 1,493.00p 1,395.00p 1,493.00p 1,135,701.00 16:35:27
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Beverages 59.3 16.8 11.6 123.9 1,652.55

Fevertree (FEVR) Latest News

More Fevertree News
Fevertree Takeover Rumours

Fevertree (FEVR) Share Charts

1 Year Fevertree Chart

1 Year Fevertree Chart

1 Month Fevertree Chart

1 Month Fevertree Chart

Intraday Fevertree Chart

Intraday Fevertree Chart

Fevertree (FEVR) Discussions and Chat

Fevertree Forums and Chat

Date Time Title Posts
22/3/201717:01Fevertree Drinks PLC (Fever-Tree)829.00
22/3/201709:18FEVER TREE with chart246.00
07/11/201423:50Is Fever Tree fairly Valued?-

Add a New Thread

Fevertree (FEVR) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
2017-03-22 17:14:581,421.561,45020,612.60O
2017-03-22 17:11:581,420.752,95141,926.21O
2017-03-22 17:10:121,425.604,06757,979.15O
2017-03-22 17:09:561,403.005738,039.19O
2017-03-22 17:09:561,455.002123,084.60O
View all Fevertree trades in real-time

Fevertree (FEVR) Top Chat Posts

DateSubject
22/3/2017
08:20
Fevertree Daily Update: Fevertree Drinks is listed in the Beverages sector of the London Stock Exchange with ticker FEVR. The last closing price for Fevertree was 1,499p.
Fevertree Drinks has a 4 week average price of 1,460.85p and a 12 week average price of 1,295.37p.
The 1 year high share price is 1,545p while the 1 year low share price is currently 592p.
There are currently 115,240,896 shares in issue and the average daily traded volume is 1,191,345 shares. The market capitalisation of Fevertree Drinks is £1,652,554,448.64.
21/3/2017
19:02
martywidget: Well, it appears the thumbs down super-duper poster has lost their tongue - must be giving Fever-tree the thumbs down perhaps. Maybe the 'chronic investor' - don't blame you personally, never read the article just post the link! Lol! Perhaps you should talk to my Parakeet Widget (Budgerigar in the UK I understand) Anyway when I asked Widget the Parakeet what he thought the Fever-Tree share price would do [short-term], and his response was down: Https://youtu.be/eQiBJXbB5Fg LOL! ;)
21/3/2017
13:45
juzzer100: Am with you there, Savvy. This is a great company - share price gives me pleasure during the day and the product gives me pleasure in the evenings.
24/1/2017
10:38
terry topper: I suppose you can look at +55% and say that it's disappointing compared to 118% from the UK. However I would say that the UK is exceptional and it is good to see FEVR taking full advantage of the 'premiumisation' especially in gin. It may be that there has been a massive focus on the UK given it's the home market and given the exceptional growth opportunity. Even with a bit of slowing in the growth rates across the various world regions, revenues >£150m and eps >35p are quite possible for 2017 - share price should get to £14-15 over the next few months IMO.
23/12/2016
09:56
jch18: Too much momentum in the share price to consider shorting. I think this will need some average news to slow /stop the momentum. I think Hotel Chocolat is far more vulnerable.
28/10/2016
15:38
terry topper: scantrader I have followed this company very closely from flotation and every announcement, including the final 2015 results, has been better than expected. I'm sure you would agree that there is no way that the share price would have performed as it has if there had been even a hint of failing to meet expectations I am not disputing what your link shows..... but I think there is something funny affecting it - I think it must be due to the way Cenkos are calculating eps. Cenkos initiated coverage on 4 Nov 2015 with a forecast for y/e 2015 of 9.6p eps. They then upgraded after the year end update to 11.9p (described as adjusted diluted). Their most recent note, from July 2016, shows 2015 actual eps as 12.2p compared to the figure reported by the company of 11.48p. I don't have time just now but will try to look into it later - I am intrigued now myself!
10/8/2016
20:18
topvest: I agree with you. It's a fabulous company. However, the share price is ridiculous. Buying at this level would be a serious error. You will need to get off before something nasty happens....it's priced at perfection and more...that always ends badly. Indeed they have already warned that UK growth can't continue at the rate it has been which stands to reason as tonic water can only sell so much.
26/7/2016
09:38
leedskier: Market Cap is quickly approaching £1bn, which is impressive for a niche company making and selling mixers for gin.But since it is one of those shares which few would even contemplate shorting, I guess it's m.c. could just keep on keeping on, as the company keeps growing it's sales or is taken over.Congratulations to those who had the wisdom to buy when it's share price was significantly lower.
26/7/2016
06:49
bookbroker: These look vulnerable, share price already reflecting strong growth, they will new products to drive growth, as I've said before it's the alcohol rather than the mixer I prefer, however if it's soft drinks you like then this co. will have to introduce a new, larger compliment of products, I am not off the belief you have to spend so much on an improved mixer, never had an issue with Schweppes tonic water!
24/3/2016
11:43
greek islander: Interesting, but we will see some seriou selling as the share price surges and big shareholders take profits. Considering the sales the share price held up well over the last few days. The share price looks heading for a high point in the near future. I find that my portfolio needs a FEVR in there to counteract the movement elsewhere. I find that in bad days and good days it goes against the general trend. Fever Tree products are more than just tonic and as customers realise it and move on to other mixers etc we should see that the revenue relies less on its figurehead product.
16/3/2016
12:11
greek islander: Everyone worries about the high PE level and it is a factor in deciding whether to buy. However, for a company that is relatively newly listed and one that is enjoying a boom in revenue levels this is not by any means out of the ordinary. It still is a modest PE compared with the early days of ASOS when the PE and the share price continued to rise dramatically for a while before it hit the wall. I can see continued revenue rises though inevitably the growth rate will eventually slow down and level off. However, this is a vibrant management with expansive momentum and is a fair bet for a further dramatic share price rise in the immediate future. I rate it still very much a buy!
Fevertree share price data is direct from the London Stock Exchange
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:35 V: D:20170323 02:20:54